Muhammad Qamar Masood: h-index, Total Citations, and Citation Map
Muhammad Qamar Masood's h-index is 15 (25 i10-index, 1,038+ total citations across 3+ publications) according to Google Scholar as of May 2026. Muhammad Qamar Masood is affiliated with Aga Khan University.
Muhammad Qamar Masood is a researcher affiliated with Aga Khan University, specializing in diabetes, endocrinology. Their work has been cited 1,038 times. This profile visualizes their global influence, highlighting strong citation networks in India.
Muhammad Qamar Masood's Citation Metrics
Bibliometric impact based on 3 indexed publications.
- H-Index
- 15
- i10-Index
- 25
- Total Citations
- 1,038
- Citing Countries
- 14
As of May 2026.
Muhammad Qamar Masood has an h-index of 15 and 1,038 total citations across 3 publications, with research cited by institutions in 14 countries.
Download Exports (PNG, CSV, Poster)
Free Viewing Muhammad Qamar Masood's citation map is always free. Pay once to download poster, PNG, and CSV files for offline use or your visa packet.
Global Impact Map
Visualizing the geographic distribution of institutions that have cited your work.
Starting…
Pins will appear here as institutions are resolved — no need to refresh.
Top Cited Works
Tip: clickto hide a row from the map
Frequency of chronic complications of type 2 diabetes
2004150
Top Citing Countries
Top Citing Institutions
Visa Evidence Package
Views and exports tuned for EB-1A, O-1A, and EB-2 NIW petitions. Sustained acclaim, geographic reach, and independent-citation filtering are the strongest evidence categories immigration adjudicators look for.
Significant Contributions
Auto-detected research lines — a seminal paper and the follow-up work building on it. Review and edit before using in a petition. Each Free PDF opens in a new tab — EB-1A organises this into the structure USCIS applies to Criterion 5 of 8 CFR § 204.5(h)(3)(v); EB-1B re-frames it under § 204.5(i)(3) (outstanding researcher); NIW presents it under prong 2 of Matter of Dhanasar.
The researcher established a foundational assessment of the frequency of chronic complications in type 2 diabetes, providing a critical baseline for understanding disease progression and clinical outcomes.
The researcher developed and validated a multicomponent quality improvement strategy for diabetes care through a randomized controlled trial, establishing an evidence-based framework for achieving clinical goals.
The researcher advanced clinical assessment of insulin resistance in PCOS by demonstrating that HOMA-IR serves as a superior diagnostic marker compared to fasting insulin levels.
Citation trend (last 10 years)Click to expand
Citation Trend (Last 10 Years)
Related Guides
Learn how to use citation maps for your research and visa applications.
